A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies

• Published in: The journal of clinical endocrinology and metabolism 1999-02, Vol.84 (2), p.702-710
• Main Authors: CHAZENBALK, G. D, YAN WANG, JIN GUO, HUTCHISON, J. S, SEGAL, D, JAUME, J. C, MCLACHLAN, S. M, RAPOPORT, B
• Format: Article
• Language: English
• Subjects: Animals; Antibodies, Monoclonal - immunology; Antibody Specificity; Antigens - chemistry; Antigens - immunology; Autoantibodies - blood; Biological and medical sciences; Chromatography - methods; Culture Media, Conditioned; Culture Techniques; Drug Stability; Endocrinopathies; Epitopes - immunology; Humans; Immunosorbent Techniques; Medical sciences; Mice; Mice, Inbred BALB C; Non tumoral diseases. Target tissue resistance. Benign neoplasms; Peptide Fragments - immunology; Protein Conformation; Protein Sorting Signals - immunology; Receptors, Thyrotropin - immunology; Receptors, Thyrotropin - isolation & purification; Temperature; Thyroid. Thyroid axis (diseases)
• ISSN: 0021-972X; 1945-7197
• DOI: 10.1210/jc.84.2.702

We used the secreted TSH receptor (TSHR) ectodomain variant TSHR-289 (truncated at amino acid residue 289 with a 6-histidine tail) to investigate properties of TSHR autoantibodies in Graves' disease. Sequential concanavalin A and Ni-chelate chromatography extracted milligram quantities of TSHR-289 (approximately 20-40% purity) from the culture medium. Nanogram quantities of this material neutralized the TSH binding inhibitory activity in all 15 Graves' sera studied. We generated a mouse monoclonal antibody (mAb), 3BD10, to partially purified TSHR-289. Screening of a TSHR complementary DNA fragment expression library localized the 3BD10 epitope to 27 amino acids at the N-terminus of the TSHR, a cysteine-rich segment predicted to be highly conformational. 3BD10 preferentially recognized native, as opposed to reduced and denatured, TSHR-289, but did not interact with the TSH holoreceptor on the cell surface. Moreover, mAb 3BD10 could extract from culture medium TSHR-289 nonreactive with autoantibodies, but not the lesser amount (approximately 25%) of TSHR-289 molecules capable of neutralizing autoantibodies. Although the active form of TSHR-289 in culture medium was stable at ambient temperature, stability was reduced at 37 C, explaining the mixture of active and inactive molecules in medium harvested from cell cultures. In conclusion, studies involving a TSHR ectodomain variant indicate the exquisite conformational requirements of TSHR autoantibodies. Even under "native" conditions, only a minority of molecules in highly potent TSHR-289 preparations neutralize patients' autoantibodies. Therefore, Graves' disease is likely to be caused by even lower concentrations of autoantibodies than previously thought. Finally, reciprocally exclusive binding to TSHR-289 by human autoantibodies and a mouse mAb with a defined epitope suggests that the extreme N-terminus of the TSHR is important for autoantibody recognition.